Short answer
DENTSPLY SIRONA Inc (XRAY) filed an 8-K current report with the SEC on October 9, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). Lenders approved covenant relief through September 30 and December 31, 2026, raising permitted total and senior leverage ratios.
DENTSPLY SIRONA Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Lenders approved covenant relief through September 30 and December 31, 2026, raising permitted total and senior leverage ratios
- EBITDA addback for specified cash charges, supporting covenant compliance during fiscal 2026
- Temporary restrictions on new liens, subsidiary debt and restricted payments, limiting financial flexibility
- Higher pricing level and incremental note interest if leverage thresholds are exceeded, increasing borrowing costs
- Quarterly reporting on initiatives, costs and savings, signaling heightened lender monitoring of operating performance
Item 2.03 · Creation of a Direct Financial Obligation
- Note Purchase Agreement Amendments and Third Amendment to Credit Agreement create or modify debt obligations
- Terms, borrowing amounts, interest rates and maturities require review of Item 1.01 for financing impact
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DENTSPLY SIRONA Inc 8-K filings
Get the next XRAY 8-K as it lands
Follow XRAY for push alerts, or ask the research agent what this filing means.